Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma

Journal of Cancer Research and Clinical Oncology

Volumn 134, Issue 12, 2008, Pages 1363-1369

  Awakura, Yasuo ^a   Nakamura, Eijiro ^a   Takahashi, Takeshi ^a   Kotani, Hirokazu ^b   Mikami, Yoshiki ^b   Kadowaki, Tadashi ^c   Myoumoto, Akira ^d   Akiyama, Hideo ^d   Ito, Noriyuki ^a   Kamoto, Toshiyuki ^a   Manabe, Toshiaki ^b   Nobumasa, Hitoshi ^d   Tsujimoto, Gozoh ^c   Ogawa, Osamu ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d TORAY INDUSTRIES INC   (Japan)

Author keywords

CDCP1; Microarray; Prognosis; Renal cell carcinoma

Indexed keywords

CUB DOMAIN CONTAINING PROTEIN 1; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CARCINOMA, RENAL CELL; CELL ADHESION MOLECULES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 54949158631     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-008-0412-4     Document Type: Article

References (27)

1. AS Bhatt H Erdjument-Bromage P Tempst CS Craik MM Moasser 2005 Adhesion signaling by a novel mitotic substrate of src kinases Oncogene 24 5333 5343
2. D Bodmer W van den Hurk JJ van Groningen MJ Eleveld GJ Martens MA Weterman AG van Kessel 2002 Understanding familial and non-familial renal cell cancer Hum Mol Genet 11 2489 2498
3. RF Chuaqui RF Bonner CJ Best JW Gillespie MJ Flaig SM Hewitt JL Phillips DB Krizman MA Tangrea M Ahram WM Linehan V Knezevic MR Emmert-Buck 2002 Post-analysis follow-up and validation of microarray experiments Nat Genet 32 Suppl 509 514
4. ME Gleave M Elhilali Y Fradet I Davis P Venner F Saad LH Klotz MJ Moore V Paton A Bajamonde 1998 Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology Group N Engl J Med 338 1265 1271
5. NS Goldstein 1999 Grading of renal cell carcinoma Urol Clin North Am 26 637 642
6. JD Hooper A Zijlstra RT Aimes H Liang GF Claassen D Tarin JE Testa JP Quigley 2003 Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen Oncogene 22 1783 1794
7. R Ihaka R Gentlaman 1996 R: a language for data analysis and graphics J Comput Graph Stat 5 299 314
8. JI Ikeda E Morii H Kimura Y Tomita T Takakuwa JI Hasegawa YK Kim Y Miyoshi S Noguchi T Nishida K Aozasa 2006 Epigenetic regulation of the expression of the novel stem cell marker CDCP1 in cancer cells J Pathol 210 75 84
9. JS Jin A Chen DS Hsieh CW Yao MF Cheng YF Lin 2006 Expression of serine protease matriptase in renal cell carcinoma: correlation of tissue microarray immunohistochemical expression analysis results with clinicopathological parameters Int J Surg Pathol 14 65 72
10. J Jones H Otu D Spentzos S Kolia M Inan WD Beecken C Fellbaum X Gu M Joseph AJ Pantuck D Jonas TA Libermann 2005 Gene signatures of progression and metastasis in renal cell cancer Clin Cancer Res 11 5730 5739
11. HL Kim D Seligson X Liu N Janzen MH Bui H Yu T Shi AS Belldegrun S Horvath RA Figlin 2005 Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma J Urol 173 1496 1501
12. F Kosari AS Parker DM Kube CM Lohse BC Leibovich ML Blute JC Cheville G Vasmatzis 2005 Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness Clin Cancer Res 11 5128 5139
13. JS Lam O Shvarts JT Leppert RA Figlin AS Belldegrun 2005 Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy J Urol 173 1853 1862
14. R Maruyama K Yamana T Itoi N Hara V Bilim T Nishiyama K Takahashi Y Tomita 2006 Absence of Bcl-2 and Fas/CD95/APO-1 predicts the response to immunotherapy in metastatic renal cell carcinoma Br J Cancer 95 1244 1249
15. A Mejean S Oudard N Thiounn 2003 Prognostic factors of renal cell carcinoma J Urol 169 821 827
16. RJ Motzer P Russo 2000 Systemic therapy for renal cell carcinoma J Urol 163 408 417
17. K Neben A Korshunov A Benner G Wrobel M Hahn F Kokocinski A Golanov S Joos P Lichter 2004 Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival Cancer Res 64 3103 3111
18. HA Nentwich Z Mustafa MS Rugg BD Marsden MR Cordell DJ Mahoney SC Jenkins B Dowling E Fries CM Milner J Loughlin AJ Day 2002 A novel allelic variant of the human TSG-6 gene encoding an amino acid difference in the CUB module. Chromosomal localization, frequency analysis, modeling, and expression J Biol Chem 277 15354 15362
19. M Scherl-Mostageer W Sommergruber R Abseher R Hauptmann P Ambros N Schweifer 2001 Identification of a novel gene, CDCP1, overexpressed in human colorectal cancer Oncogene 20 4402 4408
20. T Shimazui E Oosterwijk FM Debruyne JA Schalken 1996 Molecular prognostic factor in renal cell carcinoma Semin Urol Oncol 14 250 255
21. T Shimazui T Kojima M Onozawa M Suzuki T Asano H Akaza 2006 Expression profile of N-cadherin differs from other classical cadherins as a prognostic marker in renal cell carcinoma Oncol Rep 15 1181 1184
22. WM Stadler 2005 Targeted agents for the treatment of advanced renal cell carcinoma Cancer 104 2323 2333
23. H Sultmann A von Heydebreck W Huber R Kuner A Buness M Vogt B Gunawan M Vingron L Fuzesi A Poustka 2005 Gene expression in kidney cancer is associated with cytogenetic abnormalities, metastasis formation, and patient survival Clin Cancer Res 11 646 655
24. M Takahashi DR Rhodes KA Furge H Kanayama S Kagawa BB Haab BT Teh 2001 Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification Proc Natl Acad Sci USA 98 9754 9759
25. JR Vasselli JH Shih SR Iyengar J Maranchie J Riss R Worrell C Torres-Cabala R Tabios A Mariotti R Stearman M Merino MM Walther R Simon RD Klausner WM Linehan 2003 Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor Proc Natl Acad Sci USA 100 6958 6963
26. TJ Yeatman 2004 A renaissance for SRC Nat Rev Cancer 4 470 480
27. Y Yonezawa Y Nagashima H Sato N Virgona K Fukumoto S Shirai H Hagiwara T Seki T Ariga H Senba K Suzuki R Asano K Hagiwara T Yano 2005 Contribution of the Src family of kinases to the appearance of malignant phenotypes in renal cancer cells Mol Carcinog 43 188 197